Takeda gets FDA breakthrough therapy status for mobocertinib to treat certain type of lung cancer Read more
Merck and ISB Collaborate to Define Molecular Mechanisms of SARS-CoV-2 Infection and Identify Potential Prognostic Biomarkers Read more
Takeda Continues Divestiture Strategy with Sale of Select OTC and Non-Core Assets in Europe to Orifarm for up to approximately $670M USD Read more
Affinivax Announces $120 Million Series B Financing to Advance Pipeline of Novel MAPS Vaccines and Immunotherapies Read more